IDNA vs IVV
iShares Genomics Immunology and Healthcare ETF vs iShares Core S&P 500 ETF
Quick Verdict
IVV has a lower expense ratio. IDNA delivered stronger 1-year returns. IVV offers more diversification with 505 holdings.
Side-by-Side Comparison
| Metric | IDNA | IVV | Winner |
|---|---|---|---|
| Expense Ratio | 0.47% | 0.03% | |
| AUM | $190M | $865.2B | |
| Dividend Yield | 0.83% | 1.09% | |
| Holdings | 62 | 508 | |
| YTD Return | +34.97% | +14.50% | |
| 1Y Return | +58.42% | +22.02% | |
| 3Y Return (annualized) | +18.04% | +21.80% | |
| 5Y Return (annualized) | -6.86% | +13.37% | |
| Volatility (annualized) | 25.1% | 15.1% | |
| Max Drawdown | -68.3% | -56.5% | |
| Fund Family | iShares by BlackRock (US) | iShares by BlackRock (US) | |
| Category | Equity | Equity | |
| Inception | Jun 11, 2019 | May 15, 2000 |
IDNA vs IVV Performance
iShares Genomics Immunology and Healthcare ETF (IDNA) is a ETF from iShares by BlackRock (US) and iShares Core S&P 500 ETF (IVV) is a ETF from iShares by BlackRock (US). Over the past year IDNA returned +58.42% while IVV returned +22.02%. Year to date, IDNA is up 34.97% versus a gain of 14.50% for IVV.
Over three years, IDNA compounded at +18.04% per year against +21.80% for IVV; over five years the annualized figures are -6.86% and +13.37% respectively. Across the full 7-year window we track, IVV has the edge at +7.07% annualized vs +5.67%. Past performance does not guarantee future results.
Risk: Volatility and Drawdowns
IDNA has been the more volatile fund, with annualized monthly volatility of 25.1% compared with 15.1% for IVV. Lower volatility generally means a smoother ride, though it often comes with lower long-run returns.
The deepest peak-to-trough decline in our data was -68.3% for IDNA and -56.5% for IVV. Drawdown depth is worth weighing if you expect to sell during market stress rather than ride it out.
The two funds' monthly returns correlate at 0.59. They move independently enough that combining them can meaningfully diversify a portfolio.
Fees and Cost Over Time
IDNA charges 0.47% per year while IVV charges 0.03%. On a $10,000 position that is $47 vs $3 annually, a gap of $44 per year that compounds over a long holding period. On income, IDNA currently yields 0.83% against 1.09% for IVV.
Holdings Overlap
IDNA and IVV share 7 holdings out of 546 unique holdings combined, representing a 1.0% weight overlap.
Moderate overlap means holding both could provide meaningful diversification benefits.
Frequently Asked Questions
Which is cheaper, IDNA or IVV?
IDNA has an expense ratio of 0.47% while IVV charges 0.03%. IVV is the cheaper option. On a $10,000 investment, that is $44 per year of difference.
Which performed better, IDNA or IVV?
Over the past year IDNA returned +58.42% vs +22.02% for IVV, so IDNA leads on 1-year performance. Over the longest common window we track (7 years), IDNA annualized +5.67% vs +7.07% for IVV. Past performance does not guarantee future results.
Which is riskier, IDNA or IVV?
IDNA has been the more volatile fund at 25.1% annualized versus 15.1% for IVV. Worst drawdown: IDNA -68.3% vs IVV -56.5%.
Should I hold both IDNA and IVV?
IDNA and IVV have a monthly-return correlation of 0.59, so combining them can provide real diversification depending on your allocation goals.
What is the holdings overlap between IDNA and IVV?
IDNA and IVV share 7 common holdings with a 1.0% weight overlap. Combined, they hold 546 unique securities.
Which pays a higher dividend, IDNA or IVV?
IDNA yields 0.83% while IVV yields 1.09%, so IVV currently pays the higher dividend yield.
Popular ETF Comparisons
Get Full ETF Analytics
Access complete holdings data, overlap analysis, screener tools, and more with FundXLS.